Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407377
Max Phase: Preclinical
Molecular Formula: C30H41N3O7
Molecular Weight: 555.67
Molecule Type: Protein
Associated Items:
ID: ALA2407377
Max Phase: Preclinical
Molecular Formula: C30H41N3O7
Molecular Weight: 555.67
Molecule Type: Protein
Associated Items:
Canonical SMILES: COC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)[C@@H](O)c1ccccc1
Standard InChI: InChI=1S/C30H41N3O7/c1-19(2)16-23(32-30(38)40-18-21-12-8-6-9-13-21)27(35)33-25(26(34)22-14-10-7-11-15-22)28(36)31-24(17-20(3)4)29(37)39-5/h6-15,19-20,23-26,34H,16-18H2,1-5H3,(H,31,36)(H,32,38)(H,33,35)/t23-,24-,25+,26-/m0/s1
Standard InChI Key: QWMYFQFHIFPNEE-SSUZURRFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 555.67 | Molecular Weight (Monoisotopic): 555.2945 | AlogP: 3.25 | #Rotatable Bonds: 14 |
Polar Surface Area: 143.06 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.84 | CX Basic pKa: | CX LogP: 3.90 | CX LogD: 3.90 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.26 | Np Likeness Score: 0.11 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):